|
Promiscuous Antibody Targets Cancer Sunday, March 22, 2009 - Sarah Gingichashvili Home >> Headlines >> Cancer Research   
|
|
Researchers have challenged an old immunological dogma — that an antibody can bind to only a single target or antigen — by engineering an antibody to bind tightly to two distinct proteins. The antibody, described in Science, blocks two proteins: vascular endothelial growth factor (VEGF) and human epidermal growth factor receptor 2 (HER2). VEGF is thought to promote growth in tumours, and HER2 is highly expressed by some aggressive breast tumours. (source: nature.com)
|
|
|
|
| Related News |
|
Innate Immunity to Cancer |
|
Cancer Vaccination in Action |
| Related Pictures |
|
Purple Tomatoes to Fight Cancer |
|
New Contrast Agent to Help Fight Cancer |
| Other Articles |
|
Smart-Bombing Cancer |
|
The Future of Electronic Paper |
